Condition

Clinical Trials for Dowling-Meara Epidermolysis Bullosa Simplex

Active Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 100
  • Start Date: March 2, 2020
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 25
  • Start Date: June 14, 2018
Evaluation of the Efficacy of Injections of Botulinic Toxin in Plantar Lesions of Patients Suffering From Localized Epidermolysis Bullosa Simplex : Double Blind Randomized Controlled Study.
Search for trials
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Biological
  • Participants: 4
  • Start Date: May 7, 2018
A Phase II Study of Beremagene Geperpavec (KB103), a Non-Integrating, Replication-Incompetent Herpes Simplex Virus 1 (HSV-1) Vector Expressing the Human Collagen VII (COL7) Protein, for the Treatment of Dystrophic Epidermolysis Bullosa (DEB)
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Procedure
  • Participants: 40
  • Start Date: November 28, 2017
Computational Drug Repurposing for All Epidermolysis Bullosa Simplex (EBS) Cases
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 8
  • Start Date: May 2016
A Prospective, Double-Blind, Cross-Over, Pilot Study to Assess Safety and Efficacy of Topical Sirolimus 2% in the Treatment of Plantar Blistering in Patients With Epidermolysis Bullous Simplex (EBS)
Showing 1-5 of 5